Health
fromBoston.com
2 days agoPharma giant with large Mass. footprint to slash 9,000 jobs globally
Novo Nordisk will cut 9,000 global jobs by the end of 2026 and reallocate investment toward science, commercial capabilities, and manufacturing to focus on diabetes and obesity.